Amylin Pharmaceuticals, Inc. (AMLN)

rtart1 (80.72) Submitted: 5/21/07 4:39 PM : Start Price: $45.00 AMLN Score: -28.01

Dual purpose products approved for treating diabetes and obesity.

Report this Post Replies: 0 | Reply | Permalink

crimfunk (90.28) Submitted: 6/13/08 2:38 PM : Start Price: $26.69 AMLN Score: 0.87

bear

Report this Post Replies: 0 | Reply | Permalink

YODSTER (38.13) Submitted: 1/04/08 3:52 PM : Start Price: $36.01 AMLN Score: -21.15

I see only good things for this co. The mgmt seems to know what they are doing, diabetes is a soaring problem in this country. Making a medicine that gets rid of needles, and may even assist in weight loss can be nothing short of a great stock.

Report this Post Replies: 0 | Reply | Permalink

jlmjlm77 (29.51) Submitted: 6/11/08 12:30 PM : Start Price: $26.00 AMLN Score: 0.85

Inside buys

Report this Post Replies: 0 | Reply | Permalink

InvestorDeb (81.65) Submitted: 6/30/08 9:21 AM : Start Price: $26.42 AMLN Score: 0.37

I thought the recent pullback was overdone. No money here, just a caps pick for me.

Report this Post Replies: 0 | Reply | Permalink

drusenthian (< 20) Submitted: 5/23/08 7:10 PM : Start Price: $30.75 AMLN Score: -11.60

Carl Icahn bought >6% of stock. He's not going to sit on a sliding stock. The potential of once weekely Byetta as a stand alone therapy is huge--diabetics no longer having to stab themselves for insulin once oday but can achieve stable blood sugar wi...

Report this Post Replies: 0 | Reply | Permalink

srothstein (45.04) Submitted: 5/09/08 3:58 PM : Start Price: $28.48 AMLN Score: -4.48

New Drug In Pipeline.

Report this Post Replies: 0 | Reply | Permalink

Tankota (99.47) Submitted: 5/02/08 10:24 AM : Start Price: $28.23 AMLN Score: 1.88

"We're all going to die"

Report this Post Replies: 0 | Reply | Permalink

cuin103 (81.72) Submitted: 4/16/08 9:56 PM : Start Price: $30.80 AMLN Score: -12.82

Just a play in the biotech/big pharm acquisition game. Has some interesting drugs in pipeline that a big pharm e.g.Phizer should tuck into their thin pipeline. With a number of high revenue and margin drugs going off patent next 2-4 years something i...

Report this Post Replies: 0 | Reply | Permalink

harrier26 (< 20) Submitted: 4/02/08 3:29 AM : Start Price: $31.63 AMLN Score: -14.18

This company has some of the most interesting and promising diabetes drugs in development.

Report this Post Replies: 0 | Reply | Permalink